Evidence map›Paper›PMID 30894141›Full record

ArticleBMC nephrology2019

Design and methodology of the impact of HemoDiaFIlTration on physical activity and self-reported outcomes: a randomized controlled trial (HDFIT trial) in Brazil.

Roberto Pecoits-Filho, John W Larkin, Carlos Eduardo Poli-de-Figueiredo, Américo Lourenço Cuvello Neto, Ana Beatriz Barra, Sinaia Canhada, Ludimila Guedim de Campos, Juliane Woehl, Priscila Bezerra Gonçalves, Hao Han and 4 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02787161 (Impact of HemoDiaFIltration on Physical Activity and Self-reported Outcomes), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02787161 nacompletednot on this map

Impact of HemoDiaFIltration on Physical Activity and Self-reported Outcomes: a Randomized Controlled Trial (HD-FIT Trial)

TypeinterventionalSponsorPontifícia Universidade Católica do ParanáRan2016 to 2018Enrolled195ConditionsChronic Kidney DiseaseArmsHemodiafiltration, Hemodialysis
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Guideline
  2. Effect of hemodiafiltration on measured physical activity: primary results of the HDFIT randomized controlled trial.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Trial
  3. Trial
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Roberto Pecoits-FilhoSchool of Medicine, Pontifícia Universidade Católica do Paraná, Imaculada Conceição 1155, Curitiba, PR, 80215-901, Brazil. r.pecoits@pucpr.br.
John W LarkinSchool of Medicine, Pontifícia Universidade Católica do Paraná, Imaculada Conceição 1155, Curitiba, PR, 80215-901, Brazil.
Carlos Eduardo Poli-de-FigueiredoPontifícia Universidade Católica do Rio Grande do Sul, Av. Ipiranga 6681, Partenon, Porto Alegre, RS, 90619-900, Brazil.
Américo Lourenço Cuvello NetoHospital Alemão Oswaldo Cruz, R. Treze de Maio 1815, São Paulo, São Paulo, 01327-001, Brazil.
Ana Beatriz BarraFresenius Medical Care Brazil, R. Amoreira 891, Jaguariúna, São Paulo, 13820-000, Brazil.
Sinaia CanhadaFresenius Medical Care Brazil, R. Amoreira 891, Jaguariúna, São Paulo, 13820-000, Brazil.
Ludimila Guedim de CamposSchool of Medicine, Pontifícia Universidade Católica do Paraná, Imaculada Conceição 1155, Curitiba, PR, 80215-901, Brazil.
Juliane WoehlSchool of Medicine, Pontifícia Universidade Católica do Paraná, Imaculada Conceição 1155, Curitiba, PR, 80215-901, Brazil.
Priscila Bezerra GonçalvesHealth Technology Graduate Program, Pontifícia Universidade Católica do Paraná, Imaculada Conceição, 1155, Curitiba, PR, 80215-901, Brazil.
Hao HanFresenius Medical Care North America, 920 Winter Street, Waltham, MA, 02451, USA.
Thyago Proença de MoraesSchool of Medicine, Pontifícia Universidade Católica do Paraná, Imaculada Conceição 1155, Curitiba, PR, 80215-901, Brazil.
Jochen G RaimannResearch Division, Renal Research Institute, 315 East 62nd Street, 4th Floor, New York, NY, 10065, USA.
Maria Eugenia F CanzianiUniversidade Federal de São Paulo, R. Sena Madureira 1500, São Paulo, São Paulo, 04021-001, Brazil.
HDFIT Study Investigators
Pontifícia Universidade Católica do Paraná · BRHospital Alemão Oswaldo Cruz · BRRenal Research Institute · USUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnd stage renal disease (ESRD) patients require a renal replacement therapy (RRT) to filter accumulated toxins and remove excess water, which are associated with impaired physical function. Hemodialysis (HD) removes middle-molecular weight (MMW) toxins less efficiently compared to hemodiafiltration (HDF); we hypothesized HDF may improve physical function. We detailed the design and methodology of the HDFIT protocol that is testing whether changing from HD to HDF effects physical activity levels and various outcomes.

methodsHDFIT is a prospective, multi-center, unblinded, randomized control trial (RCT) investigating the impact of dialysis modality (HDF verses HD) on objectively measured physical activity levels, self-reported quality of life, and clinical/non-clinical outcomes. Clinically stable patients with HD vintage of 3 to 24 months without any severe limitation ambulation were recruited from sites throughout southern Brazil. Eligible patients were randomized in a 1:1 ratio to either: 1) be treated with high volume online HDF for 6 months, or 2) continue being treated with high-flux HD. This study includes run-in and randomization visits (baseline), 3- and 6-month study visits during the interventional period, and a 12-month observational follow up. The primary outcome is the difference in the change in steps per 24 h on dialysis days from baseline to the 6-month follow up in patients treated with HDF versus HD. Physical activity is being measured over one week at study visits with the ActiGraph ( www.actigraphcorp.com ). For assessment of peridialytic differences during the dialysis recovery period, we will analyze granular physical activity levels based on the initiation time of HD on dialysis days, or concurrent times on non-dialysis days and the long interdialytic day. DISCUSSION: In this manuscript, we provide detailed information about the HDFIT study design and methodology. This trial will provide novel insights into peridialytic profiles of physical activity and various self-reported, clinical and laboratory outcomes in ESRD patients treated by high volume online HDF versus high-flux HD. Ultimately, this investigation will elucidate whether HDF is associated with patients having better vitality and quality of life, and less negative outcomes as compared to HD.

trial registrationRegistered on ClinicalTrials.gov on 20 April 2016 ( NCT02787161 ).

Indexed as

Self ReportBrazilExerciseFemaleFollow-Up StudiesHemodiafiltrationHumansKidney Failure, ChronicMaleMulticenter Studies as TopicProspective StudiesRandomized Controlled Trials as TopicTreatment OutcomeAccelerometerActivities of daily living (ADL)Dialysis recoveryEnd stage renal disease (ESRD)Hemodiafiltration (HDF)Hemodialysis (HD)Physical activitySteps per day

Identifiers

PMID30894141
PMCPMC6425582
OpenAlexW2941187224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.